Description

3β-[[4-o-(6-Deoxy-β-D-Glucopyranosyl)-β-D-Glucopyranosyl]Oxy]-5,11α,14-Trihydroxy-5β,14β-Card-20(22)-Enolide is a high-purity cardiac glycoside derivative, a critical intermediate in advanced pharmaceutical synthesis. This compound is valued for its specific stereochemistry and functional groups, which are essential for developing targeted therapeutic agents. It is primarily required by research institutions, pharmaceutical development laboratories, and fine chemical manufacturers engaged in the production of specialized cardiovascular and other bioactive molecules.

Application

• Pharmaceutical Intermediate: Key starting material or advanced intermediate in the synthesis of novel cardiac glycosides and related therapeutic compounds.
• Biochemical Research: Used as a reference standard or probe in pharmacological studies to investigate sodium-potassium ATPase inhibition and cardiac cell signaling pathways.
• Active Pharmaceutical Ingredient (API) Development: Serves as a core structural component in the research and development of new drug candidates targeting heart failure and arrhythmias.
• Fine Chemical Synthesis: Employed in multi-step organic synthesis to construct complex, stereospecific molecular architectures for various biomedical applications.

Basic Information

Item	Details
Product Name	3β-[[4-o-(6-Deoxy-β-D-Glucopyranosyl)-β-D-Glucopyranosyl]Oxy]-5,11α,14-Trihydroxy-5β,14β-Card-20(22)-Enolide
CAS No.	55086-79-8
Molecular Formula	C35H54O14
Molecular Weight	698.80 g/mol
Synonyms	Gitoxin; Bigitalin; Anhydrogitalin; 16-Formylgitoxigenin 3-O-[β-D-glucopyranosyl-(1→4)-6-deoxy-β-D-glucopyranoside]; 3β-[(O-β-D-Glucopyranosyl-(1→4)-6-deoxy-β-D-glucopyranosyl)oxy]-5,11α,14-trihydroxy-19-oxo-5β,14β-card-20(22)-enolide; 16-Aldehyde of Gitoxin; Gitoxigenin 3-O-[β-D-glucopyranosyl-(1→4)-6-deoxy-β-D-glucopyranoside]
EINECS	Contact for details

Quality Control

Our 3β-[[4-o-(6-Deoxy-β-D-Glucopyranosyl)-β-D-Glucopyranosyl]Oxy]-5,11α,14-Trihydroxy-5β,14β-Card-20(22)-Enolide is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing including HPLC, NMR, and MS to ensure identity, purity, and consistency. Certificates of Analysis (COA) with full traceability are available upon request. We support development and cGMP-grade requirements for pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Loss on Drying	≤ 2.0%
Residue on Ignition	≤ 0.1%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.